INJInjective

INJ fell by 19% in the last 24 hours as selling pressure continued across the crypto market.

Cosmos Labs has bought the Mintscan blockchain explorer and formed a new South Korean subsidiary to bring the four pillars of the Cosmos network under one operator. Following the acquisition, Mintscan, Skip:Go, IBC Eureka, and the Cosmos Hub will now belong within a single operat...

Injective is set to activate the Vulcan Mainnet upgrade on June 4, 2026, following a 99.72% approval from $INJ stakers, while Merkle Capital launches the first regulated INJ fund (M-INJ) in Asia.

The battle over which execution layers will command the next major wave of on-chain trading liquidity has entered a highly specialized phase. The initial retail enthusiasm for layer-2 network points campaigns and basic token drops is gradually giving way to a more demanding standard: deep, institutional-grade execution environments and structurally superior programming models. Within this landscape, two distinct technological frameworks are attempting to disrupt the established trading dominance of Solana and Arbitrum. Sui (SUI) is aggressively leaning into its object-centric, highly parallelized Move programming language to bootstrap an ultra-fast, capital-efficient decentralized finance (DeFi) and gaming ecosystem. Simultaneously, Injective (INJ) continues to hone its identity as a blockchain custom-built for financial applications, rolling out plug-and-play order-book infrastructure designed to host the next generation of high-speed perpetual swap (perp) venues. However, looking at their 30-day technical ranges, both networks are handling multi-week corrections. Their ability to turn short-term trend-repair barriers into definitive floors will decide whether SUI and INJ can transition into permanent, sticky liquidity hubs, or if they are destined to remain high-beta alternative satellites to the market majors. Sui (SUI): Move DeFi Chain In Mid‑Range, Above Trend Support Source: tradingview Sui 's structural chart over the last 30 days reveals a technically constructive "up-from-lows" profile. Trading slightly above its 30-day Simple Moving Average (SMA) and comfortably clear of its 200-day baseline ($1.00), SUI is safely consolidating inside a well-defined mid-range channel. The Fibonacci Map ($0.95 to $1.45): 23.6% Retracement: ~$1.07 38.2% Retracement: ~$1.14 50.0% Retracement: $1.20 61.8% Retracement: ~$1.31 Immediate Support: $1.07 to $1.15: SUI is currently trading at $1.18, sitting just atop this critical trend support band. The cluster includes the 38.2% Fib ($1.14) and the 30-day SMA (~$1.15). As long as daily closes remain above the 23.6% level ($1.07), the broader upward leg is considered intact. $0.95 to $1.00: The 30-day swing low and the 200-day SMA floor. A clean daily close below $0.95 would completely unwind the current leg, plunging SUI back into its old architectural base. Immediate Resistance: $1.20 to $1.31: The primary overhead hurdle. This block spans the 50% Fib ($1.20) and the 61.8% Fib ($1.31). SUI must reclaim and sustain price action above this band to prove it is initiating a macro breakout rather than merely acting as a range-bound alternative-L1 asset. $1.40 to $1.45+: The local monthly high ceiling. A high-volume breakout and consolidation above $1.45 represents the required technical trigger to mark the start of a brand-new Move-DeFi expansion leg. The Read: Sui enters June looking like a trend-supported, mid-range network. To capture sticky trading liquidity, its dips must continue to be aggressively bought within the $1.07–$1.15 pocket. Most importantly, any future push past $1.40 must be backed by a measurable, organic expansion in native DEX Total Value Locked (TVL), proving that liquidity is staying on-chain even as short-term incentive campaigns taper off. Injective (INJ): Perp‑Focused Chain In Lower Half Of Its Range Source: tradingview Injective 's price action presents a heavier technical posture, displaying a clear down-leg correction within its broader 30-day window. While it remains safely above its long-term structural floor (200-day SMA at $24.00), it is currently pinned in the lower half of its range, beneath a sloping short-term average. The Fibonacci Map ($21.00 to $36.00): 23.6% Retracement: ~$24.54 38.2% Retracement: ~$26.73 50.0% Retracement: $28.50 61.8% Retracement: ~$30.27 Immediate Support: $24.50 to $26.00: INJ's current close ($26.00) sits at the upper boundary of this immediate "are we bouncing or breaking" support zone, which houses the 23.6% Fib ($24.54). Preserving this floor keeps the broader move from $21.00 to $36.00 intact as a partial corrective retracement. $21.00 to $22.00: The 30-day swing low. A daily close falling below $21.00 would confirm that the last run is fully unwound, signaling that early trading volume on its newer order-book venues lacks the structural conviction to hold higher price tiers. Immediate Resistance: $26.70 to $28.50: The primary trend-repair band. The 38.2% Fib sits at $26.73, while the 50% Fib and the 30-day SMA converge tightly at the top of this block ($28.50). INJ must reclaim this entire area to transition out of its "oversold perp chain" posture and flatten its moving average. $30.30 to $36.00+: The 61.8% Fib and local high resistance ceiling. Reaching this zone on high weekday volume would serve as the first genuine evidence that institutional trading desks are choosing to park long-term capital on Injective. The Read: INJ is currently heavy, trapped in the lower half of its channel with significant moving average resistance looming overhead. To validate its financial-app framework, it must defend the $24.50 baseline, clear the $28.50 resistance hurdle, and see its flagship native perp DEXs routinely post deep order-book books and competitive volume in major trading pairs. Conclusion: Real Liquidity Hubs Or High‑Beta Satellites? The side-by-side technical maps demonstrate that SUI is executing a healthier mid-range consolidation above trend support, whereas INJ requires a significant injection of buy pressure to kickstart a near-term trend repair. They Attract Sticky Trader Liquidity If: SUI successfully defends the $1.07–$1.15 trend support, breaks through the $1.31 resistance, and prints sustained daily closes above $1.45 supported by persistent on-chain gaming and trading activity. INJ vigorously holds the $24.50 floor, reclaims the $26.70–$28.50 moving average block, and spends the majority of its trading volume grinding toward $36.00 while proving its on-chain order books do not empty out between marketing campaigns. Sophisticated market makers and derivative traders explicitly choose to maintain capital allocations on SUI and INJ even during periods when Solana and Arbitrum are exhibiting massive relative strength. They Remain High-Beta Alternatives If: SUI fails to preserve its $1.07 trend line, drifting back toward the $0.95 floor and confirming that its relief rallies are consistently sold off near $1.30. INJ remains trapped beneath the $27.00 block, spending the summer grinding sideways to down between $21.00 and $26.00 while failing to claim its short-term moving average. The vast majority of institutional liquidity and high-frequency trading volume remains deeply anchored to Solana and dominant Ethereum L2 rollups, leaving SUI and INJ to behave as speculative satellites used purely for narrative-driven capital rotation. Final Verdict: The charts outline a "constructive but not yet leading" alignment for Sui and an "early repair, still heavy" posture for Injective. Both assets possess clearly mapped step-up zones. The upcoming weeks will test whether the actual deep execution advantages of the Move language and native financial chains can translate into structural, persistent liquidity dominance, or if they will remain secondary options on the market's trading desk. Disclaimer: This article is provided for informational purposes only. It is not offered or intended to be used as legal, tax, investment, financial, or other advice.

The total altcoin market cap revisited a technical structure linked to previous crypto rotations. ADA, XRP, FET, INJ, and RENDER remained among the most discussed altcoins during the latest rebound. Analysts continued monitoring capital rotation away from Bitcoin dominance into a...

Discover how Injective and Internet Computer lead the AI market shift while Kevin O'Leary's recent keynote highlights why ZKP is the best crypto presale. Read original article on coinlineup.com

The AI narrative in crypto has been the defining trade of 2026, and June is making that obvious in a way nobody can ignore. Injective is up roughly 73% over thirty days. Internet Computer broke out of a months-long consolidation and squeezed shorts into oblivion. Both are riding ...

Injective price pulled back sharply over the past 24 hours, but the broader context tells a much bigger story than a single day of losses. INJ dropped 4.00%, almost matching Bitcoin’s 3.93% decline during a wider market selloff that pushed the total crypto market capitalization d...

INJ's breakout gained support from expanding liquidity and strengthening on-chain activity.